CD38 and leukemia: Various surface markers, such as CD93, CD69, and CD36, have been found to demarcate distinct subpopulations of immunophenotypically sorted HSC-like cells (CD34+CD38−) that differ in leukemia initiating activity and cell cycle status [48–50].